The Latest Headlines at American Banking and Market News
Q3 2024 EPS Estimates for X4 Pharmaceuticals, Inc. Cut by Brookline Capital Management (NASDAQ:XFOR)
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Free Report) – Research analysts at Brookline Capital Management dropped their Q3 2024 earnings per share (EPS) estimates for shares of X4 Pharmaceuticals in a research note issued... More of this article »
Brokers Offer Predictions for Lassonde Industries Inc’s Q3 2024 Earnings (TSE:LAS)
Lassonde Industries Inc (TSE:LAS – Free Report) – Equities research analysts at National Bank Financial upped their Q3 2024 earnings estimates for shares of Lassonde Industries in a research note issued on Tuesday,... More of this article »
B. Riley Comments on Lindblad Expeditions Holdings, Inc.’s Q3 2024 Earnings (NASDAQ:LIND)
Lindblad Expeditions Holdings, Inc. (NASDAQ:LIND – Free Report) – Equities researchers at B. Riley upped their Q3 2024 earnings estimates for Lindblad Expeditions in a report released on Tuesday, April 30th. B. Riley... More of this article »
The Lion Electric Company Forecasted to Post Q3 2024 Earnings of ($0.07) Per Share (TSE:LEV)
The Lion Electric Company (TSE:LEV – Free Report) – B. Riley lowered their Q3 2024 earnings estimates for shares of Lion Electric in a note issued to investors on Tuesday, April 30th. B. Riley analyst C. Souther now... More of this article »
Brokers Set Expectations for Ag Growth International Inc.’s Q3 2024 Earnings (TSE:AFN)
Ag Growth International Inc. (TSE:AFN – Free Report) – Stock analysts at Atb Cap Markets cut their Q3 2024 earnings per share (EPS) estimates for Ag Growth International in a report released on Tuesday, April 30th.... More of this article »
Scotiabank Increases Gibson Energy (TSE:GEI) Price Target to C$26.00
Gibson Energy (TSE:GEI – Get Free Report) had its price target upped by equities researchers at Scotiabank from C$25.00 to C$26.00 in a research note issued on Wednesday, BayStreet.CA reports. The brokerage presently has an... More of this article »
Knight Therapeutics (TSE:GUD) PT Raised to C$5.40 at Stifel Nicolaus
Knight Therapeutics (TSE:GUD – Get Free Report) had its price target boosted by research analysts at Stifel Nicolaus from C$5.25 to C$5.40 in a research report issued to clients and investors on Wednesday, BayStreet.CA reports.... More of this article »
Ivanhoe Mines (TSE:IVN) PT Raised to C$22.00 at Canaccord Genuity Group
Ivanhoe Mines (TSE:IVN – Get Free Report) had its price objective hoisted by analysts at Canaccord Genuity Group from C$21.00 to C$22.00 in a research report issued on Wednesday, BayStreet.CA reports. The firm currently has... More of this article »
K-Bro Linen (TSE:KBL) PT Raised to C$47.50 at Acumen Capital
K-Bro Linen (TSE:KBL – Get Free Report) had its price objective increased by stock analysts at Acumen Capital from C$46.00 to C$47.50 in a research report issued on Wednesday, BayStreet.CA reports. The firm currently has a “buy”... More of this article »
BMO Capital Markets Increases Ivanhoe Mines (TSE:IVN) Price Target to C$22.00
Ivanhoe Mines (TSE:IVN – Get Free Report) had its price objective boosted by stock analysts at BMO Capital Markets from C$18.00 to C$22.00 in a research report issued to clients and investors on Wednesday, BayStreet.CA reports.... More of this article »
National Bankshares Downgrades Newmont (TSE:NGT) to Sector Perform
Newmont (TSE:NGT – Get Free Report) was downgraded by investment analysts at National Bankshares from an “outperform” rating to a “sector perform” rating in a note issued to investors on Wednesday, BayStreet.CA... More of this article »
Ivanhoe Mines (TSE:IVN) PT Raised to C$22.00 at Royal Bank of Canada
Ivanhoe Mines (TSE:IVN – Get Free Report) had its price target raised by Royal Bank of Canada from C$19.00 to C$22.00 in a report issued on Wednesday, BayStreet.CA reports. The firm currently has an “outperform”... More of this article »
Ivanhoe Mines (TSE:IVN) PT Raised to C$19.00 at Scotiabank
Ivanhoe Mines (TSE:IVN – Get Free Report) had its target price upped by equities research analysts at Scotiabank from C$18.00 to C$19.00 in a research report issued on Wednesday, BayStreet.CA reports. The firm currently has... More of this article »